Azure Linux 4.0 is Microsoft's own Fedora-derived Linux distro for Azure cloud workloads. Here is how it compares to Ubuntu, ...

Databricks, a data software company, plans to sell shares to the public at some point, but won’t tap the public markets this year amid a flurry of planned tech IPOs. The company wants to sell shares ...

Arsalan Tavakoli was at his bachelor party in 2013 when Ali Ghodsi, a computer science researcher at the University of California, Berkeley, pulled him aside. The two had become colleagues and friends ...

ShengShu Technology officially introduced Vidu Claw in Singapore on May 8, 2026. The platform is being described as the world’s first “AI CMO,” short for AI Chief Marketing Officer. Its main goal is ...

Speaking at WSJ Opinion Live in Washington, D.C., WSJ Editorial Page Editor Paul Gigot and SandboxAQ CEO Jack Hidary discuss Large Quantitative Models (LQMs) and their role in AI applications, the ...

Databricks has previewed a new open agentic Security Information and Event Management software (SIEM) named Lakewatch that signals its first deliberate step beyond data warehousing into security ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Company plans to use funds to accelerate AI database, Genie assistant JPMorgan Chase leads $2 billion debt financing Databricks' AI products cross $1.4 billion in annualized revenue Feb 9 (Reuters) - ...

Deadline’s Read the Screenplay series spotlighting the scripts behind the awards season’s most talked-about movies continues with Warner Bros‘ Weapons. Writer-director Zach Cregger described the ...

For a spec screenwriter looking for a way into the studio system, few things are better than landing on The Black List. “Twenty-one years into this experiment, it still feels a little miraculous that ...

In the announcement, Cigna's top brass noted that while significant progress has made around affordability for generics, which make up the vast majority of prescriptions, and biosimilars, branded drug ...